{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:42:59Z","timestamp":1793108579042,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ccm.2025.12.017","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T20:30:56Z","timestamp":1774297856000},"page":"365-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Customizing Antibiotic Treatment for Pneumonia"],"prefix":"10.1016","volume":"47","author":[{"given":"Takaya","family":"Maruyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Niederman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ccm.2025.12.017_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases Society of America and the American thoracic society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2025.12.017_bib2","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2025.12.017_bib3","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","author":"Niederman","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2025.12.017_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7326\/0003-4819-150-1-200901060-00005","article-title":"Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia","volume":"150","author":"Venditti","year":"2009","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.ccm.2025.12.017_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/cid\/cir274","article-title":"Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study","volume":"53","author":"Chalmers","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.ccm.2025.12.017_bib6","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/thoraxjnl-2013-203828","article-title":"Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case-control study","volume":"68","author":"Polverino","year":"2013","journal-title":"Thorax"},{"issue":"18","key":"10.1016\/j.ccm.2025.12.017_bib7","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.2169\/internalmedicine.51.7987","article-title":"Clinical characteristics of nursing and healthcare-associated pneumonia: a Japanese variant of healthcare-associated pneumonia","volume":"51","author":"Ishida","year":"2012","journal-title":"Intern Med"},{"issue":"8","key":"10.1016\/j.ccm.2025.12.017_bib8","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1164\/rccm.201301-0079OC","article-title":"Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia","volume":"188","author":"Shindo","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.ccm.2025.12.017_bib9","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/cid\/cit734","article-title":"Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis","volume":"58","author":"Chalmers","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.ccm.2025.12.017_bib10","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1128\/AAC.00851-07","article-title":"Health care-associated pneumonia and community-acquired pneumonia: a single-center experience","volume":"51","author":"Micek","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ccm.2025.12.017_bib11","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1378\/chest.128.6.3854","article-title":"Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia","volume":"128","author":"Kollef","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2025.12.017_bib12","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1001\/archinte.168.20.2205","article-title":"Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia","volume":"168","author":"Shorr","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ccm.2025.12.017_bib13","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/cid\/cit571","article-title":"A new strategy for healthcare-associated pneumonia:a 2-year prospective multicenter cohort study using risk factors for multidrug resistant pathogens to select initial empiric therapy","volume":"57","author":"Maruyama","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ccm.2025.12.017_bib14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1378\/chest.127.1.213","article-title":"Multicenter study of hospital-acquired pneumonia in non-ICU patients","volume":"127","author":"Sopena","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2025.12.017_bib15","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/cid\/ciy631","article-title":"A therapeutic strategy for all pneumonia patients: a 3-year prospective multicenter-cohort study using risk factors for multidrug resistant pathogens to select initial empiric therapy","volume":"68","author":"Maruyama","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2025.12.017_bib16","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1164\/rccm.201708-1717LE","article-title":"Evaluation of the 2016 infectious diseases society of America\/American Thoracic Society guideline criteria for risk of multidrug-resistant pathogens in patients with hospital-acquired and ventilator-associated pneumonia in the ICU","volume":"197","author":"Ekren","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"157","key":"10.1016\/j.ccm.2025.12.017_bib17","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0023-2020","article-title":"Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia?","volume":"29","author":"Vallecoccia","year":"2020","journal-title":"Eur Respir Rev"},{"issue":"4","key":"10.1016\/j.ccm.2025.12.017_bib18","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.rmed.2009.12.008","article-title":"Community-acquired pneumonia and nursing home-acquired pneumonia in the very elderly patients","volume":"104","author":"Maruyama","year":"2010","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.ccm.2025.12.017_bib19","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/thx.2009.124776","article-title":"Nursing home-acquired pneumonia: a 10 year single-centre experience","volume":"65","author":"Polverino","year":"2010","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.ccm.2025.12.017_bib20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/thoraxjnl-2011-200630","article-title":"Nursing-home-acquired pneumonia in Germany: an 8-year prospective multicentre study","volume":"67","author":"Ewig","year":"2012","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.ccm.2025.12.017_bib21","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccm.2007.08.004","article-title":"Pneumonia in the older patient","volume":"28","author":"Niederman","year":"2007","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.ccm.2025.12.017_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1513\/AnnalsATS.201407-305OC","article-title":"Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia","volume":"12","author":"Prina","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.ccm.2025.12.017_bib23","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cir840","article-title":"Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia","volume":"54","author":"Aliberti","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2025.12.017_bib24","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1128\/AAC.03071-15","article-title":"Derivation and multicenter validation of the drug resistance in pneumonia clinical prediction score","volume":"60","author":"Webb","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.ccm.2025.12.017_bib25","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.resinv.2025.06.014","article-title":"The JRS guideline for the management of pneumonia in adults 2024","volume":"63","author":"Mukae","year":"2025","journal-title":"Respir Investig"},{"key":"10.1016\/j.ccm.2025.12.017_bib26","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01190-2017","article-title":"Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia:a multinational point prevalence study of hospitalised patients","volume":"52","author":"Restrepo","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2025.12.017_bib27","first-page":"169","article-title":"The risk factors of multidrug-resistant organisms in hospitalized patients with community-acquired pneumonia in Dr. Soetomo Hospital surabaya, Indonesia","volume":"53","author":"Soedarsono","year":"2021","journal-title":"Acta Med Indones"},{"key":"10.1016\/j.ccm.2025.12.017_bib28","doi-asserted-by":"crossref","unstructured":"Wu CL, Ku SC, Yang KY, et al. Antimicrobial drug-resistant microbes associated with hospitalized community-acquired and healthcare-associated pneumonia:a multi-center study in Taiwan. J Formos Med Assoc. 2013; 112: 31-40.","DOI":"10.1016\/j.jfma.2011.09.028"},{"key":"10.1016\/j.ccm.2025.12.017_bib29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/1060028020935106","article-title":"Risk factor evaluation for methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in community-acquired pneumonia","volume":"55","author":"Lewis","year":"2021","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ccm.2025.12.017_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/resp.12651","article-title":"Predictors of pseudomonas and methicillin-resistant Staphylococcus aureus in hospitalized patients with healthcare-associated pneumonia","volume":"21","author":"Metersky","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.ccm.2025.12.017_bib31","doi-asserted-by":"crossref","first-page":"704","DOI":"10.5588\/ijtld.12.0723","article-title":"Validation of a scoring tool to predict drug-resistant pathogens in hospitalized pneumonia patients","volume":"17","author":"Park SC Kim","year":"2013","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.ccm.2025.12.017_bib32","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1378\/chest.09-2434","article-title":"Resistant pathogens in nonnosocomial pneumonia and respiratory failure:is it time to refine the definition of health-care-associated pneumonia?","volume":"137","author":"Schreiber","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2025.12.017_bib33","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S1473-3099(16)30267-5","article-title":"Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP):an international, observational cohort study","volume":"16","author":"Aliberti","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ccm.2025.12.017_bib34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejim.2021.10.005","article-title":"Risk factors for community-onset pneumonia caused by drug-resistant pathogens:a prospective cohort study","volume":"96","author":"Barreto","year":"2022","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ccm.2025.12.017_bib35","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.chest.2016.03.042","article-title":"Community-acquired pneumonia due to Multidrug- and non-multidrug resistant Pseudomonas aeruginosa","volume":"150","author":"Cilloniz","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2025.12.017_bib36","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000362673","article-title":"Risk factors for acquiring potentially drug-resistant pathogens in immunocompetent patients with pneumonia developed out of hospital","volume":"88","author":"Jeong","year":"2014","journal-title":"Respiration"},{"issue":"4","key":"10.1016\/j.ccm.2025.12.017_bib37","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s00134-012-2808-5","article-title":"Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors","volume":"39","author":"Martin-Loeches","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ccm.2025.12.017_bib38","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jiac.2022.02.012","article-title":"Risk factors for antibiotic resistance in hospital-acquired and ventilator-associated pneumonia","volume":"28","author":"Sano","year":"2022","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ccm.2025.12.017_bib39","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00582-2017","volume":"50","author":"Torres","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2025.12.017_bib40","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/511702","article-title":"Pathogens in early-onset and late-onset intensive care unit-acquiredpneumonia","volume":"28","author":"Verhamme","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ccm.2025.12.017_bib41","first-page":"S126","article-title":"Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj hospital:etiology, clinical outcomes, and impact of antimicrobial resistance","volume":"93","author":"Werarak","year":"2010","journal-title":"J Med Assoc Thail"},{"key":"10.1016\/j.ccm.2025.12.017_bib42","first-page":"S23","article-title":"Acinetobacter baumannii nosocomial pneumonia in tertiary carehospitals in Thailand","volume":"95","author":"Werarak","year":"2012","journal-title":"J Med Assoc Thail"},{"key":"10.1016\/j.ccm.2025.12.017_bib43","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jinf.2016.11.008","article-title":"Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance","volume":"74","author":"Fern\u00e1ndez-Barat","year":"2017","journal-title":"J Infect"},{"key":"10.1016\/j.ccm.2025.12.017_bib44","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10096-020-04046-9","article-title":"Clinical and microbiological characteristics of adults with hospital-acquired pneumonia:a 10-year prospective observational study in China","volume":"40","author":"Yin","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.ccm.2025.12.017_bib45","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00134-023-07033-8","article-title":"ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia","volume":"49","author":"Martin-Loeches","year":"2023","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.ccm.2025.12.017_bib46","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00735-2022","article-title":"ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia","volume":"61","author":"Martin-Loeches","year":"2023","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ccm.2025.12.017_bib47","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.chest.2024.02.025","article-title":"Anaerobic antibiotic coverage in aspiration pneumonia and the associated benefits and harms: a retrospective cohort study","volume":"166","author":"Bai","year":"2024","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.ccm.2025.12.017_bib48","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S2213-2600(23)00412-5","article-title":"Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial","volume":"12","author":"Giamarellos-Bourboulis","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ccm.2025.12.017_bib49","article-title":"Association between the sequence of beta-lactam and vancomycin administration and mortality in patients with suspected sepsis","volume":"5","author":"Kondo","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2025.12.017_bib50","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijantimicag.2011.11.005","article-title":"A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalization","volume":"39","author":"Nicholson","year":"2012","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.ccm.2025.12.017_bib51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/cid\/ciu219","article-title":"A phase 3 randomized double-blind comparison of Ceftobiprole Medocaril versus ceftazidime plus linezolid for the treatment of hospital-acquired pneumonia","volume":"59","author":"Awad","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2025.12.017_bib52","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz149","article-title":"Randomized trial of ceftazidime-avibactam vs Meropenem for treatment of hospital-acquired and ventilator-associated bacterial pneumonia (REPROVE):Analyses per US FDA-specified end points","volume":"6","author":"Torres","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"12","key":"10.1016\/j.ccm.2025.12.017_bib53","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S1473-3099(19)30403-7","article-title":"Ceftolozane\u2013tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial","volume":"19","author":"Kollef","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ccm.2025.12.017_bib54","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1473-3099(20)30731-3","article-title":"Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia(APEKS-NP):a phase 3, randomised, double-blind, non-inferiority study","volume":"21","author":"Wunderink","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.ccm.2025.12.017_bib55","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40121-018-0214-1","article-title":"Effect and safety of meropenem\u2013vaborbactam versus best-available therapy in patients with carbapenem-resistant enterobacteriaceae infections: the TANGO II randomized clinical trial","volume":"7","author":"Wunderink","year":"2018","journal-title":"Infect Dis Ther"},{"issue":"11","key":"10.1016\/j.ccm.2025.12.017_bib56","doi-asserted-by":"crossref","first-page":"e4539","DOI":"10.1093\/cid\/ciaa803","article-title":"A randomized, double-blind, multicenter trial comparing efficacy and safety of Imipenem\/Cilastatin\/relebactam versus piperacillin\/tazobactam in adults with hospital-acquired or ventilator-associated bacterial pneumonia (RESTORE-IMI 2 study)","volume":"73","author":"Titov","year":"2021","journal-title":"Clin Infect Dis"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523125001194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523125001194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T15:35:58Z","timestamp":1779809758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523125001194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0272523125001194"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2025.12.017","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Customizing Antibiotic Treatment for Pneumonia","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2025.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}